Private Label Tranexamic Acid Vitamin C Eye Patch Manufacturer

Most private label eye patch manufacturers accept a minimum order of 500 to 3,000 pairs per SKU for a first production run, though the exact number depends on several factors. Hydrogel-base patches typically carry a lower floor — often 500 to 1,500 pairs — because the production tooling is more standardized. Bio-cellulose patches, which require more complex manufacturing infrastructure, usually start at 1,000 to 3,000 pairs. What moves MOQ up or down includes formula complexity, active concentrations, packaging customization, and whether you're using an ODM (off-the-shelf formula you private label) versus a full OEM (a custom formula developed for your brand). ODM routes almost always carry lower MOQs — sometimes as few as 300 pairs — because the manufacturer has already amortized formulation costs across multiple clients. OEM projects cost more to develop and usually require higher minimums, anywhere from 2,000 to 10,000 pairs, because the factory needs to justify the R&D and stability testing investment. Geography also matters. Korean contract manufacturers (K-beauty OEM/ODM) are globally recognized for low-MOQ patch production and often accommodate 500-pair trial runs for indie brands. Chinese manufacturers can go lower on unit cost but frequently require higher minimums and have longer revision cycles due to communication lag and regulatory translation complexity. US and EU-based formulators who can produce eye patches in-house typically have MOQs of 1,000 to 5,000 but offer faster regulatory alignment for domestic markets. If you absolutely need under 500 pairs for a soft launch or product validation, look for a contract manufacturer that offers a sample or pilot batch program. These programs produce 50 to 200 pairs at a higher per-unit cost — often $4–$8 per pair — purely for consumer testing, trade show sampling, or influencer seeding before committing to a full production run. When negotiating MOQ, ask the manufacturer to separate the setup fees (die-cutting tooling, foil sealing calibration, formula batch records) from the per-unit cost. Sometimes you can achieve a lower MOQ by paying a one-time setup surcharge — typically $500 to $2,000 — rather than absorbing it spread across units. AJ Cosmo Labs lets you filter manufacturers on the app by MOQ tier, so you only spend time talking to suppliers who can actually serve your launch scale.

The timeline from initial brief to finished goods in your warehouse runs 10 to 22 weeks for a first production run of private label eye patches, broken into distinct stages. Understanding what happens in each phase helps you avoid the most common mistake founders make: compressing the timeline and skipping stability testing. Weeks 1–2: Briefing and supplier selection. You finalize your formula spec (base type, active percentages, co-actives, scent if any, packaging format) and shortlist manufacturers. If you use a platform like AJ Cosmo Labs, this stage can compress to a few days because you post a brief and receive qualified responses instead of cold-searching directories. Weeks 2–5: Formula development and sampling. For ODM projects, the factory sends you a pre-existing formula matching your brief; you evaluate the sample and request tweaks. For OEM, the cosmetic chemist develops a custom formula, which takes 2–4 weeks before a first sample is ready. Expect 1–3 revision rounds, each adding 1–2 weeks. Weeks 5–8: Stability and compatibility testing. Accelerated stability testing (40°C/75% RH) runs for a minimum of 4 weeks before the manufacturer can claim a 12-month shelf life projection. Tranexamic acid and vitamin C (especially ascorbic acid) are notoriously sensitive to oxidation and pH shifts, so this step cannot be skipped. Responsible manufacturers also run compatibility testing between the formula and the packaging material (foil, tray, outer carton) to check for migration or degradation. Weeks 8–10: Regulatory documentation. Your manufacturer provides the batch formula, CoA, SDS, and INCI list. If you need a US Cosmetic Product Safety Report (required under MoCRA) or an EU CPSR, budget 2–4 additional weeks for an independent safety assessor to review and sign off. Weeks 10–14: Packaging production. Die-cut molds, custom foil pouch artwork, tray inserts, and outer carton printing all run in parallel with formula finalization. Artwork proofing and color matching can add 1–2 weeks if there are revisions. Weeks 14–18 (or up to 22): Production, QC, and shipping. The actual fill-seal-pack run for a 500–3,000 pair batch typically takes 1–2 weeks. Post-production QC (microbial testing, leak testing, weight check) adds another week. Sea freight from South Korea or China adds 3–5 weeks; air freight reduces that to 1–2 weeks at significantly higher cost. Reorder runs, once the formula and packaging are locked, compress to 6–10 weeks because development and stability phases are already complete. Planning your inventory cycle around this reorder timeline is critical to avoiding stockouts on a product that performs well at retail.

Total cost of launching a private label eye patch line breaks into three buckets: formulation and development costs, per-unit manufacturing costs, and regulatory and packaging costs. First-time founders consistently underestimate the second and third buckets. Formulation and development costs range from $0 for pure ODM (no custom development, you private label a stock formula) to $3,000–$15,000 for a full OEM custom formula. The OEM cost covers the cosmetic chemist's time, stability testing, and batch documentation. At the lower end, $3,000–$6,000 gets you a basic custom formula with one active stack; at the higher end, $8,000–$15,000 covers a complex formula with multiple sensitive actives, multiple stability time points, and full safety dossier preparation. Per-unit manufacturing costs depend on base type, MOQ, and active concentration. At a 500-pair MOQ, expect $1.50–$3.50 per pair for hydrogel patches and $2.50–$5.00 per pair for bio-cellulose patches. At 5,000 pairs, hydrogel drops to $0.80–$1.80 per pair and bio-cellulose to $1.50–$3.00. These figures typically include bulk formula, patch substrate, foil pouch, and a basic tray, but exclude the outer retail box. Packaging costs are often the surprise. Custom die-cut tooling runs $500–$2,000 as a one-time setup fee. Outer carton printing at 500–1,000 units costs $0.30–$0.80 per unit; at 5,000+ units it drops to $0.10–$0.25. If you want a premium rigid box, add $0.50–$2.00 per unit. Regulatory and compliance costs for a US-only launch include a safety assessment ($1,500–$3,500 from an independent toxicologist), label review by a regulatory consultant ($500–$1,500), and FDA facility registration verification (your manufacturer handles this, but confirm it's current). EU addition requires a full CPSR ($2,000–$5,000) and CPNP notification. Total launch budget for a first run of 1,000 pairs with a stock ODM formula, custom packaging, and US regulatory compliance typically falls between $8,000 and $20,000. A full OEM custom formula at the same unit count runs $15,000–$35,000. Founders who budget under $5,000 for a first eye patch launch consistently run into cash shortfalls mid-development. AJ Cosmo Labs helps you get itemized quotes from multiple vetted manufacturers so you can compare cost structures before committing.

The stability of vitamin C in an aqueous, sealed patch format is the central formulation challenge when combining it with tranexamic acid. Ascorbic acid (L-AA) is the most bioavailable form and the most studied, but it is also the most oxidation-prone. In a hydrogel or bio-cellulose patch where the formula sits sealed against a moist substrate for its entire shelf life, standard ascorbic acid at concentrations above 10% can oxidize, turn yellow-orange, and degrade within 6–12 months even in foil packaging — especially if the pH is not tightly controlled between 3.0 and 3.5. For eye patches specifically, cosmetic chemists most commonly recommend one of three stable vitamin C derivatives: Ascorbyl Glucoside (AA2G) is water-soluble, highly stable across a pH range of 4.5–7.0, and enzymatically converted to ascorbic acid on the skin. It is the most popular choice for Asian OEM eye patch manufacturers because it maintains potency through 24–36 month stability windows. Effective use concentrations run 2–10%. Sodium Ascorbyl Phosphate (SAP) is another water-soluble ester with excellent stability and a strong safety profile around the periorbital area. It functions well at 5–10% and pairs cleanly with tranexamic acid without ionic interference. Magnesium Ascorbyl Phosphate (MAP) offers good stability, is less irritating than straight ascorbic acid, and has clinical data supporting collagen synthesis and brightening claims. It is slightly more expensive than SAP but preferred by some formulators for sensitive skin positioning. Transexamic acid (TXA) in the formula needs to be evaluated for compatibility with whichever vitamin C derivative you select. TXA is a water-soluble amino acid derivative that is stable across a broad pH range (4.5–7.5) and does not typically create stability conflicts with ascorbyl derivatives — unlike pure ascorbic acid, which can create oxidative instability cascades in the presence of metal ions common in water. The common first-timer mistake is specifying ascorbic acid at 10–15% because it sounds more potent on a marketing claim, only to receive stability data showing 30–40% active degradation at the 6-month mark. Your cosmetic chemist should run a forced degradation study on the formula before committing to a production batch. When evaluating manufacturers through AJ Cosmo Labs, specifically ask which vitamin C forms they have existing validated stability data for in patch formats — that data already exists saves you 4–6 weeks of development.

Tranexamic acid eye patches are cosmetics, not drugs, under US FDA jurisdiction — provided the product is marketed with cosmetic claims only. The FDA does not approve cosmetics before they go to market; instead, it holds brands and manufacturers responsible for the safety and accurate labeling of their products. A cosmetic claim describes how the product affects appearance: "visibly reduces the look of dark circles," "brightens the under-eye area," or "evens skin tone around the eye." These are permissible cosmetic claims. A drug claim describes a physiological effect on body structure or function: "treats hyperpigmentation," "repairs skin cells," or "inhibits melanin production." Using drug language on a cosmetic product triggers FDA classification as an over-the-counter drug, which requires pre-market approval (via a New Drug Application or OTC monograph compliance) and dramatically changes your regulatory obligations and cost structure. Under the Modernization of Cosmetics Regulation Act (MoCRA), which became enforceable in late 2023 and into 2024, US cosmetic brands face new requirements: facility registration for domestic manufacturers, product listing with the FDA, and maintenance of safety substantiation records. Importers bringing finished eye patches from a foreign manufacturer must ensure the foreign facility is also registered. MoCRA does not change what is a cosmetic vs. a drug — it adds a compliance layer for all cosmetics. For the EU, cosmetics are regulated under Regulation (EC) No 1223/2009. Tranexamic acid is not a prohibited or restricted ingredient in the EU at concentrations used cosmetically (typically 1–5%), but you must have a Cosmetic Product Safety Report (CPSR) signed by a qualified safety assessor before placing the product on the EU market, and the product must be notified in the Cosmetic Products Notification Portal (CPNP). The responsible person (RP) in the EU — a legal entity with an EU address — must be named on the label. In South Korea, tranexamic acid is classified as a quasi-drug ingredient (기능성화장품) for its skin brightening function, which means Korean-manufactured eye patches with TXA at functional concentrations may require additional registration if you intend to sell domestically in Korea. For export to the US or EU, the Korean factory manufactures to your destination market's standards, so Korean domestic quasi-drug rules do not apply to your product's regulation in the US. Neither the FDA nor the EU require pre-market approval for your cosmetic eye patches, but both require that you have safety data on file. Budget for a US safety assessment and, if selling in Europe, a full EU CPSR before your first commercial shipment.

Finding a genuinely vetted, low-MOQ eye patch manufacturer requires more than a Google search or a trade directory scan. Most directories list manufacturers without verifying GMP certification, active ingredient expertise, or willingness to actually work with indie brands — which means you can spend weeks emailing factories that either ignore you or quote MOQs ten times your budget. The most reliable channels, in rough order of time efficiency: Specialized B2B marketplaces designed for CPG founders — like AJ Cosmo Labs — are the fastest route for small brands. You post a brief describing your product, target MOQ, active percentages, and packaging format, and suppliers respond directly. Every manufacturer on AJ Cosmo Labs has been vetted for credentials, so you're not filtering through unregistered brokers or traders posing as factories. Download the app from the App Store and post your brief in under five minutes. K-beauty OEM/ODM sourcing agencies connect you with South Korean factories that specialize in sheet masks and patches. Korea has the most developed low-MOQ patch manufacturing ecosystem in the world, with hundreds of factories experienced in hydrogel and bio-cellulose substrates. Agencies charge 5–15% sourcing fees but can navigate language and logistics barriers efficiently. Cosmetic trade shows — Cosmoprof North America (Las Vegas), in-cosmetics Global (Europe), and Cosmopack (Bologna) — aggregate hundreds of contract manufacturers in one location. Eye patch OEM/ODM suppliers with English-speaking reps are common at these events. The drawback is shows happen once or twice a year, so you're constrained by the calendar. LinkedIn and industry-specific forums (Reddit's r/DIYBeauty, Beauty Independent's sourcing communities) surface founder referrals — arguably the highest-trust source because another brand has already done the vetting work and validated that the factory performs at low MOQ. When evaluating any manufacturer, request the following before signing an agreement: ISO 22716 GMP certificate (verify it's current, not expired), FDA facility registration number (for US-bound product), three brand references in your SKU category, sample stability data for a comparable active-loaded patch, and a draft private label agreement that assigns IP ownership to you. A factory that cannot or will not provide these documents is disqualified regardless of how low their price quote is. The most common mistake indie founders make when sourcing: selecting a manufacturer based on the lowest per-unit quote without verifying stability testing infrastructure. A cheap manufacturer who can't run accelerated stability testing will cost you far more in reformulation, chargebacks, and brand reputation damage than a slightly more expensive vetted partner.

Eye patch packaging operates at two levels: the primary containment (what touches or immediately surrounds the patch) and the secondary packaging (the outer retail unit the consumer sees on shelf or online). Getting both right affects product stability, perceived brand equity, and your landed cost per unit. Primary packaging options include: Foil laminate pouches are the most common and cost-effective primary format. A three-side-seal or four-side-seal foil pouch provides an excellent oxygen and moisture barrier, protecting sensitive actives like vitamin C from oxidative degradation. Pouches can be clear-front/foil-back or fully opaque. Custom printing on foil pouches typically requires a minimum print run of 5,000–10,000 units for offset printing; digital printing can start at 500 units at a higher per-unit cost. Transparent PET or PET/foil combo pouches offer a see-through window to display the patch, which performs well in e-commerce photography. The tradeoff is slightly lower barrier properties than fully opaque foil — verify with your cosmetic chemist that the formula stability is acceptable in this format. Tray-in-pouch configurations hold the patches in a molded tray (often PP or PET) inside the foil pouch, preventing the patches from folding or sticking together. This is a premium format that significantly elevates unboxing experience and justifies higher retail price points, but adds $0.15–$0.50 per unit in packaging cost. Single-use sachets (individual foil packets per pair) are common for sample programs, travel retail, and subscription box formats. Unit cost is higher per pair but allows unit-by-unit retail pricing ($3–$8 per sachet is common in prestige channels). Secondary packaging options include: Folding carton boxes (paperboard, offset or digital printed, with or without foil stamping, embossing, or soft-touch laminate) are the standard retail outer. A simple CMYK box at 1,000 units costs $0.30–$0.60 per unit; a premium box with special finishes runs $0.80–$2.50. Rigid setup boxes are used for prestige gifting and DTC luxury positioning. They add $2–$6 per unit and require longer lead times for the box component. Shipper/mailer boxes for DTC brands need to be designed for transit protection without adding excessive weight that increases per-shipment carrier costs. Sustainability is an increasing buyer and retailer consideration. FSC-certified paperboard, soy-based inks, and compostable or recyclable foil alternatives are available from many packaging suppliers, though compostable barrier films still have limitations in protecting oxidation-sensitive formulas. Discuss your sustainability goals with both your patch manufacturer and your packaging supplier early in development — retrofitting sustainable packaging after product launch is more expensive and time-consuming than building it into the original brief. AJ Cosmo Labs connects you with both patch manufacturers and packaging designers who can align on these specs from day one.